Real-time enrollment status for this multiple myeloma clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 10:11 AM UTC
| NCT Number | NCT04879043 |
| Recruiting Status | Recruiting |
| Condition | Multiple Myeloma |
| Phase | Clinical Trial |
| Target Enrollment | 78 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Heidelberg Pharma AG |
| Last Updated on CT.gov | July 24, 2024 (Jul 24, 2024) |
As of March 2, 2026: Clinical trial NCT04879043 is currently recruiting participants. This clinical trial study for multiple myeloma is actively seeking new participants at 3 locations across the United States. The study is sponsored by Heidelberg Pharma AG. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04879043 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04879043 was last updated Jul 24, 2024 (July 24, 2024). HelloStudys verifies this status automatically.